TP53 and neuroblastoma: Since newly diagnosed human NBs are almost invariably p53 wild type and preclinical data indicate that NB cells are strikingly sensitive to Nut-3 in in vitro and in xenograft models [13], [15], translation of the p53 restoration therapy in the treatment of high-risk NB patients urges.